Formulation development and evaluation of gastroretentive mucoadhesive tablets of glimepiride using natural polymers
Glimepiride, a third-generation sulfonylurea is poorly soluble anti-diabetic drug. Currently, the use of natural gums and mucilage is of increasing importance in pharmaceutical formulations as valuable drug excipients. Natural plant-based materials are economic, free of side effects, biocompatible and biodegradable. The development of mucoadhesive sustained release drug delivery system is recommended in order to enhance the bioavailability. A mucoadhesive tablets were developed using the natural polymer sodium alginate and gum tragacanth. Mucoadhesion is a complex phenomenon which involves wetting, adsorption and interpenetration of polymer chains. The tablets of glimepiride were prepared by direct compression method. Pre-compression parameters were evaluated. The tablets were evaluated for post-compression parameters such as thickness, hardness, average weight, friability and In vitro release studies. All the compositions were resulted in adequate pharmacopoeial limits. The varying concentration of polymers was found to affect on in-vitro drug release and mucoadhesive strength. In vitro drug release of gastro retentive tablet of glimepiride shown that the formulation F5 was found to be the best formulation as it releases 98.78%. Glimepiride in a sustain release manner for an extended period of time (up to 12 hrs). The release data was fitted to various mathematical models such as higuchi, korsmeyer-peppas, first order and zero order to evaluate the kinetics and mechanism of the drug release. Prepared tablets of glimepiride may prove to be a potential candidate for safe and effective controlled drug delivery over an extended period of time for gastro retentive drug delivery system.
Keywords: Glimepiride, Gastro retentive, Anti-diabetic drug, Direct compression method
2. Sachin CM, Venkateshwarlu BS, Bhowmik D, Jayakar B. Formulation and evaluation of controlled release mucoadhesive oral tablet of clarithromycin. Der Pharmacia Lettre, 2009; 1(1):83-91.
3. Bagul U, Gujar K, Dhat S, et al. In vitro study of mucoadhesive strength of polymers for mucoadhesive drug delivery systems. Int J Curr Pharm Res, 2009; 1(1):42-46.
4. Gavin P, Thomas PL, David SJ. Mucoadhesive polymeric platforms for controlled drug delivery. Eup J Pharm Biopharm, 2009; 505-518.
5. Parthiban KG, Kumar BS, Manivannan R, kumar DS. Once daily gastro retentive mucoadhesive cephalexin monohyrate tablet: Formulation and in-vitro evaluation. Int J Pharm Sci Res, 2010; 1(5):89-98.
6. Kiran T, Shastri N, Ramakrishna S, Sadanandam M. Surface solid dispersion of glimepiride for enhancement of dissolution rate. Int J Pharm Tech Res, 2009; 1:822-831.
7. Ning X, Sun J, Han X, et al. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Dev Ind Pharm, 2011; 37:727-736.
8. Rajpurohit VS, Rakha P, Goyal S, et al. Formulation and characterization of solid dispersions of glimepiride through factorial design. Iran J Pharm Sci. 2011; 7:7-16.
9. Pachisia N, Agrawal SS, Formulation, development and evaluation of transdermal drug delivery system of glimepiride. Int J Pharm Pharm Sci Res. 2012; 1-8.
10. Rani TS, Sujatha S, Veeresham C. Pharmacokinetic and phamacodynamic interaction of curcumin with glimepiride in normal and diabetic rats. Pharmacog Commun, 2012; 2:14-21.
11. Pattanayak DP, Dinda SC. Bilayer tablet formulation of metformin hydrochloride and glimepiride: A novel approach to improve therapeutic efficacy. Int J Drug Disc Herb Res, 2011; 1:1-4.
12. Alhalmi A, Altowairi M, Saeed O, et al. Sustained release matrix system: an overview, World Journal of Pharmacy and Pharmaceutical Sciences; 2018; 7(6):1470- 1486.
13. Singh R, Malviya R, Sharma P. Extraction and characterization of tamrind seed polysaccharide as pharmaceutical excipients. Pharmacognosy Journal, 2011; 3(20):17.
14. Abdul HM, Lokeswara BV, Pal N; Formulation and Evaluation of Sustained Release Matrix Tablets of Glimepiride Based on Combination of Hydrophilic and Hydrophobic Polymers; Journal of Applied Pharmaceutical Science; 2012; 2(6):101- 107.
15. Gupta S, Dev A. Formulation and characterization of mucoadhesive matrix tablet of nizatidine. Asian J Pharm Clin Res, 2018; 11(6):277-283.
16. Sinko PJ. Physical Pharmacy and Pharmaceutical Sciences, Lippincott Williams and Wilkins, 5th Edition, 2006.
17. Chein Y W. Novel drug delivery systems, Marcel Dekker, INC, 2nd edition, 1992, 140.
18. Liberman HA, Lachman L, Schwartz JB. Pharmaceutical dosage forms: Tablets, 3rd edition, Marcel Dekker, New York, 1990.
19. Hadjiioannou TP, Christian GD, Koupparis MA. VCH Publishers Inc.; New York, USA: 1993. Quantitative calculations in pharmaceutical practice and research.
20. Salsa T, Veiga F, Pina ME. Drug Dev Ind Pharm. 1997; 23:929-938.
21. Polymers for mucosal delivery-Swelling and mucoadhesive evaluation. Indian Drugs, 2002, 39(5):270-276
22. Shinkar DM, Dhake AS, Setty CM. Drug delivery from the oral cavity: a focus on mucoadhesive buccal drug delivery systems. PDA J Pharm Sci and Tech 2012; 66:466-500.
23. Derle D, Pawar A, Patel J, et al. Formulation and evaluation of buccoadhesive bi-layer tablet of propranolol hydrochloride. International Journal of Pharmacy and Pharmaceutical Sciences, 2009; 1(1):45-50.
24. Brahmankar DM, Jaiswal SB. Biopharmaceutis and Pharmacokinetics: A Tretise, Vallabh Prakashan, New Delhi, 1st edition, 2006, 335-357.
25. Costa P, Lobo ML. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences. 2001; 13(2):123-133.
26. Korsemeyer RW, Gurny R, Doelker EM, et al. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm, 1983;15:25-35.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).